Skip to content
value.today

Pace Surgical, Inc.

Formerly Pace Medical, Inc.

Total raised
$4 M
3 rounds on record
Latest round
$1 M
Dec 2025
First round on record
Feb 2024
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pace Surgical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2025$1 MNo. 3Under $2 million

Pace Surgical, Inc.: Raise no. 3, Dec 2025

Investors in this round

11 investors had bought by the notice of Feb 17, 2026: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$38,100
Finders' fees
none
Paid to its own people
$200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey F. O'Donnell, Jr. · Executive Officer, Director
  • Jeffrey F. O'Donnell, Sr. · Executive Officer, Director
  • William Scott Rhoda · Executive Officer, Director
  • Harry Thomas Hall, IV · Director
  • Nicholas Thomas Pachuda · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • "Alere Financial Partners, A division of Cova Capital Partners LLC (""Alere""))" (CRD 109761) · Syosset, New YorkSold in MA, NC, NY, PA, TX

Signed by Jeffrey F. O'Donnell, Jr,, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 17, 2026. Read the notice at the SEC.

equity, optionsSEC
Jul 2025$1 MNo. 2Under $2 million

Pace Surgical, Inc.: Raise no. 2, Jul 2025

Investors in this round

15 investors had bought by the notice of Jul 18, 2025: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$35,700
Finders' fees
none
Paid to its own people
$160,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffery F. O'Donnell, Jr. · Executive Officer, Director
  • Jeffrey F. O'Donnell, Sr. · Executive Officer, Director
  • William Scott Rhoda · Executive Officer, Director
  • Harry Thomas Hall, IV · Director
  • Nicholas Thomas Pachuda · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • "Alere Financial Partners, A division of Cova Capital Partners LLC (""Alere""))" (CRD 109761) · Syosset, New YorkSold in CA, FL, NC, NY, PA, TX

Remarks in the notice

  • On fees: “In addition to the commission, the broker-dealer will receive 6% warrant coverage on commissioned sales.”

Signed by Jeffrey F. O'Donnell, Jr,, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 18, 2025. Read the notice at the SEC.

equitySEC
Feb 2024$1 MNo. 1Under $2 million

Pace Surgical, Inc.: Raise no. 1, Feb 2024

Investors in this round

1 investor had bought by the notice of Mar 4, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$350,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey F. O'Donnell, Jr. · Executive Officer, Director
  • Jeffrey F. O'Donnell, Sr. · Executive Officer, Director
  • William Scott Rhoda · Executive Officer, Director
  • Michael F. West · Director
  • Nicholas F. Pachuda · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The amount sold reflects an amount paid in cash and an amount paid in consideration of the transfer of assets in connection with a Technology Acquisition Agreement.”

Signed by Jeffrey F. O'Donnell, Jr., Ceo. Source: SEC Form D, newest notice filed Mar 4, 2024. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pace Surgical, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2026).

    SEC Form D · Feb 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2026

That is all the official record says: Pace Surgical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pace Surgical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pace Surgical, Inc.
NameRoleNamed in
Jeffrey F. O'Donnell, Jr.Executive officerFeb 2026
Jeffrey F. O'Donnell, Sr.Executive officerFeb 2026
William Scott RhodaExecutive officerFeb 2026
Jeffery F. O'Donnell, Jr.Executive officerJul 2025
Harry Thomas Hall, IVDirectorFeb 2026
Jeffrey F. O'Donnell, Jr.DirectorFeb 2026
Jeffrey F. O'Donnell, Sr.DirectorFeb 2026
Nicholas Thomas PachudaDirectorFeb 2026
William Scott RhodaDirectorFeb 2026
Jeffery F. O'Donnell, Jr.DirectorJul 2025
Michael F. WestDirectorMar 2024
Nicholas F. PachudaDirectorMar 2024